Article
Astragaloside IV alleviates lipopolysaccharide-induced preeclampsia-like phenotypes via suppressing the inflammatory responses.
The Kaohsiung journal of medical sciences - 1 Mar 2021
Tuerxun Dilihuma, Aierken Remila, Zhang Yan-Mei, Huang Ying, Sui Shuang, Li Xiao-Ying, Abulikemu Zulifeiya, Dilixiati Nuerbiye
Abstract excerpt
Preeclampsia (PE) is a major cause of perinatal and maternal mortality and morbidity, which affects 2% to 8% of pregnancies in the world. The aberrant maternal inflammation and angiogenic imbalance have been demonstrated to contribute to the pathogenesis of PE. This research aimed to investigate the effect of Astragaloside IV (AsIV) in the treatment of PE and the underlying mechanisms. A rat PE-like model was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.